| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2024 | Jan 5, 2024 | OPKO HEALTH, INC. | Director | Buy | 86.3 | +25,000 | 8.33% | ✗ | $23.4K |
| Nov 13, 2023 | Nov 14, 2023 | OPKO HEALTH, INC. | Director | Buy | 86.3 | +25,000 | 9.09% | ✗ | $32.5K |
| Nov 8, 2023 | Nov 8, 2023 | GeneDx Holdings Corp. | Director | Buy | 91.3 | +10,000 | 91.59% | ✗ | $14.9K |
| Aug 17, 2023 | Aug 18, 2023 | GeneDx Holdings Corp. | Director | Buy | 91.3 | +5,000 | 84.49% | ✗ | $25.5K |
| May 18, 2023 | May 22, 2023 | GeneDx Holdings Corp. | Director | Buy | 91.3 | +5,000 | 544.66% | ✗ | $29.5K |
| Aug 20, 2021 | Aug 23, 2021 | Cocrystal Pharma, Inc. | Director | Buy | 91.3 | +40,000 | 100.00% | ✗ | $41.1K |
| Oct 25, 2019 | Oct 25, 2019 | OPKO HEALTH, INC. | Director | Buy | 91.3 | +25,000 | 10.00% | ✗ | $36.2K |
| May 22, 2019 | May 23, 2019 | OPKO HEALTH, INC. | Director | Buy | 95.0 | +30,000 | 13.64% | ✗ | $61.5K |
| May 13, 2019 | May 14, 2019 | OPKO HEALTH, INC. | Director | Buy | 95.0 | +50,000 | 29.41% | ✗ | $102.5K |